The targeting of inflammation has emerged as a promising therapeutic strategy for cerebral ischaemia. Here the authors show that TIM-3, a member of the T-cell immunoglobulin and mucin domain protein family, is upregulated in glial cells and plays a role in inflammation-associated brain injury under hypoxic conditions.
- Han Seok Koh
- Chi Young Chang
- Eun Jung Park
